科研日历

订阅

MedSci主页 / 所有栏目 / 科研日历

30. 针对肿瘤相关研究设计的Tips有哪些?

2021-11-10 MedSci原创 MedSci原创

关注

梅斯医学-科研日历知识点_30

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1643010, encodeId=8511164301023, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Thu Apr 14 02:28:20 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194220, encodeId=09981194220d9, content=<a href='/topic/show?id=925fe34453b' target=_blank style='color:#2F92EE;'>#研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73445, encryptionId=925fe34453b, topicName=研究设计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:52:58 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800512, encodeId=8cda1800512b4, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Jun 03 23:28:20 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377795, encodeId=05a313e779580, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Nov 13 06:28:20 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2022-04-14 yige2011

    #TIPS#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1643010, encodeId=8511164301023, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Thu Apr 14 02:28:20 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194220, encodeId=09981194220d9, content=<a href='/topic/show?id=925fe34453b' target=_blank style='color:#2F92EE;'>#研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73445, encryptionId=925fe34453b, topicName=研究设计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:52:58 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800512, encodeId=8cda1800512b4, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Jun 03 23:28:20 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377795, encodeId=05a313e779580, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Nov 13 06:28:20 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2022-02-16 医者仁者

    #研究设计#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1643010, encodeId=8511164301023, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Thu Apr 14 02:28:20 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194220, encodeId=09981194220d9, content=<a href='/topic/show?id=925fe34453b' target=_blank style='color:#2F92EE;'>#研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73445, encryptionId=925fe34453b, topicName=研究设计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:52:58 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800512, encodeId=8cda1800512b4, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Jun 03 23:28:20 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377795, encodeId=05a313e779580, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Nov 13 06:28:20 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2022-06-03 shenxlcyp

    #相关研究#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1643010, encodeId=8511164301023, content=<a href='/topic/show?id=131e1e4771a' target=_blank style='color:#2F92EE;'>#TIPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17477, encryptionId=131e1e4771a, topicName=TIPS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f99023051810, createdName=yige2011, createdTime=Thu Apr 14 02:28:20 CST 2022, time=2022-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194220, encodeId=09981194220d9, content=<a href='/topic/show?id=925fe34453b' target=_blank style='color:#2F92EE;'>#研究设计#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73445, encryptionId=925fe34453b, topicName=研究设计)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Wed Feb 16 22:52:58 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1800512, encodeId=8cda1800512b4, content=<a href='/topic/show?id=cbf9e254051' target=_blank style='color:#2F92EE;'>#相关研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72540, encryptionId=cbf9e254051, topicName=相关研究)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Fri Jun 03 23:28:20 CST 2022, time=2022-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377795, encodeId=05a313e779580, content=<a href='/topic/show?id=17b810004ce' target=_blank style='color:#2F92EE;'>#iPS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10004, encryptionId=17b810004ce, topicName=iPS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69cb413, createdName=chengjn, createdTime=Sat Nov 13 06:28:20 CST 2021, time=2021-11-13, status=1, ipAttribution=)]
    2021-11-13 chengjn

    #iPS#

    0